Global health and foreign policy are intersecting in critical ways as nations compete in a high-stakes global race to fund, and in some cases produce, Covid-19 vaccinations for beneficiary countries. As manufacturing and distribution capabilities evolve, countries such as Russia and China are opting to contribute fixed supplies of vaccines to certain countries of strategic importance, while the United States and its allies have instead preferred to fund programs such as COVAX, a global initiative with a mission to support equitable access. How has China integrated its own brand of vaccine diplomacy into a broader foreign policy strategy? What do nations such as Russia, India, United Arab Emirates, and Israel stand to gain from such great efforts in global health? Additionally, how has focused funding for programs like COVAX affected the leverage of wealthy democracies abroad? Please join us for an in-depth discussion of vaccine diplomacy when we will be joined by Dr. Krishna Udayakumar, Director of the Duke Global Health Innovation Center and Dr. David Ellwood, Senior Adjunct Professor of European and Eurasian Studies at SAIS Europe.
---
Upcoming events: [ Ссылка ]
Follow us at:
Twitter: @Network2020
LinkedIn: Network 20/20
Facebook: @network2020
Instagram: @network_2020
---
